肺炎患者中甲素敏感性黄金葡萄球菌引起的风炎的快速进展:一个病例报告
Hideya Itagaki1, Tomoya Ooizumi1, Chiho Sanada2
1Department of Emergency and Disaster Medicine, Tohoku Medical and Pharmaceutical University Hospital, Sendai, JPN.
Cureus
|March 25, 2024
概括
这份病例报告详细介绍了一名因肺炎住院患者的致命感染大动脉动脉瘤. 尽管最初对黄金葡萄球菌进行了抗生素治疗,但动脉瘤迅速进展,导致死亡.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 血管外科 血管外科
背景情况:
- 感染性大动脉动脉瘤是罕见的,但危及生命的血管并发症.
- 及时诊断和治疗对于患者的治疗结果至关重要.
相关概念视频
Pneumonia III: Complications and Assessment
206
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
206
Pneumonia I: Introduction
233
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
233
Pneumonia II: Pathophysiology
262
The pathophysiology of pneumonia involves the following steps:
262
Pneumonia IV: Management
324
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324


